Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Taiminen

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Acta Psychiatrica Scandinavica|April 1, 1999
Depression Scale (DEPS) in schizophreniaJ Huttunen, T Taiminen, J Kähkönen, et al.
Nordisk Medicin|January 1, 1995
[Emergency psychiatric treatment of survivors of the Estonia disaster]T Taiminen, T Tuominen, J Strandberg, et al.
Neurology|August 25, 2004
APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injuryS Koponen, T Taiminen, V Kairisto, et al.
The Journal of Nervous and Mental Disease|February 1, 1996
Prediction of positive placebo response among chronic schizophrenic outpatientsT Taiminen, E Syvalahti, S Saarijarvi, et al.
The Journal of Nervous and Mental Disease|November 5, 1997
Is positive placebo response in chronic schizophrenia investigator-dependent?T Taiminen, E Syvälahti, S Saarijärvi, et al.
Schizophrenia Research|January 17, 1997
Effect of smoking on neuroleptics in schizophreniaR K Salokangas, S Saarijärvi, T Taiminen, et al.
Nordic Journal of Psychiatry|January 23, 2002
Comparison of clinical and best-estimate research DSM-IV diagnoses in a Finnish sample of first-admission psychosis and severe affective disorderT Taiminen, K Ranta, H Karlsson, et al.
Acta Psychiatrica Scandinavica|September 1, 1996
Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled studyR K Salokangas, S Saarijärvi, T Taiminen, et al.
The Journal of International Medical Research|January 1, 1997
Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patientsE K Syvälahti, T Taiminen, S Saarijärvi, et al.
Schizophrenia Research|March 30, 2001
The Schizophrenia Suicide Risk Scale (SSRS): development and initial validationT Taiminen, J Huttunen, H Heilä, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Acta Psychiatrica Scandinavica|April 1, 1999
Depression Scale (DEPS) in schizophreniaJ Huttunen, T Taiminen, J Kähkönen, et al.
Nordisk Medicin|January 1, 1995
[Emergency psychiatric treatment of survivors of the Estonia disaster]T Taiminen, T Tuominen, J Strandberg, et al.
Neurology|August 25, 2004
APOE-epsilon4 predicts dementia but not other psychiatric disorders after traumatic brain injuryS Koponen, T Taiminen, V Kairisto, et al.
The Journal of Nervous and Mental Disease|February 1, 1996
Prediction of positive placebo response among chronic schizophrenic outpatientsT Taiminen, E Syvalahti, S Saarijarvi, et al.
The Journal of Nervous and Mental Disease|November 5, 1997
Is positive placebo response in chronic schizophrenia investigator-dependent?T Taiminen, E Syvälahti, S Saarijärvi, et al.
Schizophrenia Research|January 17, 1997
Effect of smoking on neuroleptics in schizophreniaR K Salokangas, S Saarijärvi, T Taiminen, et al.
Nordic Journal of Psychiatry|January 23, 2002
Comparison of clinical and best-estimate research DSM-IV diagnoses in a Finnish sample of first-admission psychosis and severe affective disorderT Taiminen, K Ranta, H Karlsson, et al.
Acta Psychiatrica Scandinavica|September 1, 1996
Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled studyR K Salokangas, S Saarijärvi, T Taiminen, et al.
The Journal of International Medical Research|January 1, 1997
Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patientsE K Syvälahti, T Taiminen, S Saarijärvi, et al.
Schizophrenia Research|March 30, 2001
The Schizophrenia Suicide Risk Scale (SSRS): development and initial validationT Taiminen, J Huttunen, H Heilä, et al.
Pageof 3